Effect of gender affirming hormones on athletic performance in transwomen and transmen: implications for sporting organisations and legislators
- 7 December 2020
- journal article
- research article
- Published by BMJ in British Journal of Sports Medicine
- Vol. 55 (11) , 577-583
Abstract
Objective To examine the effect of gender affirming hormones on athletic performance among transwomen and transmen. Methods We reviewed fitness test results and medical records of 29 transmen and 46 transwomen who started gender affirming hormones while in the United States Air Force. We compared pre- and post-hormone fitness test results of the transwomen and transmen with the average performance of all women and men under the age of 30 in the Air Force between 2004 and 2014. We also measured the rate of hormone associated changes in body composition and athletic performance. Results Participants were 26.2 years old (SD 5.5). Prior to gender affirming hormones, transwomen performed 31% more push-ups and 15% more sit-ups in 1 min and ran 1.5 miles 21% faster than their female counterparts. After 2 years of taking feminising hormones, the push-up and sit-up differences disappeared but transwomen were still 12% faster. Prior to gender affirming hormones, transmen performed 43% fewer push-ups and ran 1.5 miles 15% slower than their male counterparts. After 1 year of taking masculinising hormones, there was no longer a difference in push-ups or run times, and the number of sit-ups performed in 1 min by transmen exceeded the average performance of their male counterparts. Summary The 15–31% athletic advantage that transwomen displayed over their female counterparts prior to starting gender affirming hormones declined with feminising therapy. However, transwomen still had a 9% faster mean run speed after the 1 year period of testosterone suppression that is recommended by World Athletics for inclusion in women’s events.Keywords
This publication has 20 references indexed in Scilit:
- Body composition, bone turnover, and bone mass in trans men during testosterone treatment: 1-year follow-up data from a prospective case–controlled study (ENIGI)European Journal of Endocrinology, 2015
- Preservation of volumetric bone density and geometry in trans women during cross-sex hormonal therapy: a prospective observational studyOsteoporosis International, 2014
- Bone Mass, Bone Geometry, and Body Composition in Female-to-Male Transsexual Persons after Long-Term Cross-Sex Hormonal TherapyThe Journal of Clinical Endocrinology & Metabolism, 2012
- Equality, Equity and Inclusion: Transgender Athletes' Participation in Competitive Sports - a New EraPhysical Culture and Sport. Studies and Research, 2010
- Body Composition and Bone Mineral Density in Male-to-Female Transsexuals During Cross-Sex Hormone Therapy Using Gonadotrophin-Releasing Hormone AgonistExperimental and Clinical Endocrinology & Diabetes, 2010
- Body composition, volumetric and areal bone parameters in male-to-female transsexual personsBone, 2008
- Transsexuals and competitive sportsEuropean Journal of Endocrinology, 2004
- Effects of Androgenic-Anabolic Steroids in AthletesSports Medicine, 2004
- Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexualsAmerican Journal of Physiology-Endocrinology and Metabolism, 1999
- Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic governmentClinical Chemistry, 1997